Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
08/2007
08/14/2007US7256219 Multifluoro-substituted chalcones and analogs as activators of caspases and inducers of apoptosis and the use thereof
08/14/2007US7256216 Powder mixture of aminobutyric acid and solid polyol; therapy for brain disorders; central nervous system disorders; analgesics; headaches
08/14/2007US7256210 7-amido-isoindolyl compounds and methods of their use
08/14/2007US7256201 Selective estrogen receptor-β ligands
08/14/2007US7256194 Compounds that inhibit factor Xa activity
08/14/2007US7256188 3-aminoalkyl-2-aryl-indole derivatives and their use as GnRH antagonists
08/14/2007US7256158 Animal husbandry; veterinary medicine
08/14/2007CA2271607C Process for stabilizing cyanohydrins
08/09/2007WO2007089149A2 Water-soluble cc-1065 analogs and their conjugates
08/09/2007WO2007088190A1 Benzo (f) isoindol-2-ylphenyl acetic acid derivatives as ep4 receptor agonists
08/09/2007WO2007088189A1 Benzoisoindole derivatives for the treatment of pain
08/09/2007WO2007087684A1 Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors
08/09/2007US20070185335 improved method; chemical condensation in presence of catalytic hydrogenation catalyst; hydrogenolysis; amidation; angiotensin-converting enzyme (ACE) inhibitor; hypotensive agent for treating hypertension and congestive heart failure
08/09/2007US20070185207 Indol-7 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
08/09/2007US20070185186 Compositions for the delivery of substituted napthyl indole derivatives and methods of their use
08/09/2007US20070185184 Carbazole derivatives
08/09/2007US20070185183 Indolinesulphanilic acid amides as ppar-delta modulators
08/09/2007US20070185171 Compounds and methods of use
08/09/2007US20070185161 N-[3-(1-Ethyl-5-fluoro-indan-1-yl)-1H-indol-7-yl]-methanesulfonamide; for treating congestive heart disease, hypertension, and atherosclerosis
08/09/2007US20070185158 Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
08/09/2007US20070185151 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists
08/09/2007US20070185137 Therapy for disease caused by nicotinic receptors; cognition activatrors; central nervous system disorders
08/09/2007US20070184091 Animal feed composition
08/09/2007US20070184024 RNA polymerase, HCV metalloprotease, HCV serine protease, HCV polymerase, HCV helicase inhibitor; liver disease; (+/-)-8-Cyclohexyl-N-4-(morpholinosulfonyl)-1,1a,2,12b-tetrahydro-11-methoxy-1a-(3-methyl-3,8-diazabicyclo[3.2.1]octane-8-carbonyl)cycloprop[d]indolo[2,1-a][2]benzazepine-5-carboxamide
08/09/2007CA2641899A1 Water-soluble cc-1065 analogs and their conjugates
08/09/2007CA2640678A1 Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors
08/09/2007CA2640277A1 Benzo (f) isoindol-2-ylphenyl acetic acid derivatives as ep4 receptor agonists
08/09/2007CA2640274A1 Benzoisoindole derivatives for the treatment of pain
08/08/2007EP1814900A1 Agonists and antagonists of the somatostatin receptor
08/08/2007EP1814869A2 Substituted amino acids as protein tyrosine phosphatase inhibitors
08/08/2007EP1506202B1 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
08/08/2007EP1432681B1 Pseudopolymorphic forms of carvedilol
08/08/2007EP1277736B1 Novel bicyclic compounds
08/08/2007EP1268424B1 Method for synthesis of perindopril and its pharmaceutically acceptable salts
08/08/2007EP1255752B1 Pyrrole substituted 2-indolinone protein kinase inhibitors
08/08/2007CN1330651C Fused heterocyclic compounds
08/08/2007CN1330644C Hydrolysis of [R(R*,R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxide
08/08/2007CN1330614C Diphenyl anthracene derivate and organic electroluminescent apparatus using diphenyl anthracene derivate
08/08/2007CN1330307C Indole, azaindole and related heterocyclic amidopiperazine derivatives
08/08/2007CN101014581A Novel piperidine derivative for the treatment of depression
08/08/2007CN101014569A Oxime ester initiators
08/08/2007CN101014568A Small molecule inhibition of a pdz-domain interaction
08/07/2007US7253292 Synthesis of cyclopentadiene derivatives
08/07/2007US7253291 Processes for the preparation of N-substituted phthalimides
08/07/2007US7253203 Indoline derivatives
08/07/2007US7253194 Compounds and inhibitors of phospholipases
08/07/2007US7253179 pyrido[4,3-b]carbazol derivatives; melanin-concentrating hormone (MCH) and somatostatin receptors modulator; eating disorders; obesity; anxiolytic agents; psychological disorders
08/07/2007US7253172 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid
08/07/2007US7252815 using carbocyanine dye; photodynamic therapy; supplying to tumor
08/07/2007CA2210973C Method of preparing retroviral protease inhibitor intermediates
08/02/2007WO2007087488A2 Indole sulfonamide modulators of progesterone receptors
08/02/2007WO2007086584A1 NOVEL INHIBITOR OF FabK AND FabI/K
08/02/2007WO2007086534A1 Organic field effect transistor and semiconductor device
08/02/2007WO2007085679A1 Preparation of beta-carboline from natural products and foods having monoaminooxidase (mao) inhibiting activity
08/02/2007WO2007065684A3 Bicyclic heteroyclic compounds as antiinflammatory or antiallergic agents
08/02/2007WO2007017602A3 Marqueurs, leur procede de fabrication et leurs applications
08/02/2007WO2006112549A8 Fused heterocyclic compound
08/02/2007US20070179315 of aromatic groups using transition metal catalysis in compressed carbon dioxide; intermediates
08/02/2007US20070179302 metathesis, starting from a renewable raw materials vegetable or animal oils to produce a chemical intermediate for renewable polymer(polyesters, polyamides) or biolubricants
08/02/2007US20070179297 Chemical compounds
08/02/2007US20070179154 Coumarin derivatives, process for their production and use thereof
08/02/2007US20070179142 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
08/02/2007US20070178512 Modified carbocyanine dyes and their conjugates
08/02/2007US20070178511 Modified carbocyanine dyes and their conjugates
08/02/2007CA2637933A1 Indole sulfonamide modulators of progesterone receptors
08/01/2007EP1813602A1 Crystal of two-ring heterocyclic sulfonamide compound
08/01/2007EP1812426A1 Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease
08/01/2007EP1812389A1 Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
08/01/2007EP1812388A1 Sulfonamide pert-substituted bicyclics for occlusive artery disease
08/01/2007EP1811993A2 Modulators of crth2, cox-2 and faah
08/01/2007EP1811844A1 Methods for diagnosis and treatment of cancer
08/01/2007EP1461038B1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
08/01/2007EP1377542B1 Hiv protease inhibitors based on amino acid derivatives
08/01/2007CN1329376C Preparation method and medical uses of Nú¿1ú®-hydrocarbyl-3'-nitrotylindirubin derivative (I)
08/01/2007CN1329360C Preparation of substituted phthalic anhydride
08/01/2007CN101010297A N-(1h-indolyl)-1h-indole-2-carboxamide derivatives, their preparation and their therapeutic use
08/01/2007CN101010296A Piperazine derivatives of alkyhydroxy indole
08/01/2007CN101010006A Herbicide combinations comprising special ketoenoles
08/01/2007CN101007783A Process for preparing biphthalimide
08/01/2007CN101007782A Bi(N-methylphthalic imidine) ester preparation method
08/01/2007CN101007781A Synthesis of phenolic monomers containing imide or diimide moieties and high heat carbonate polymers prepared therefrom
08/01/2007CN101007780A Large scale preparation method for 3-[2-(dimethylamido)ethyl]-N-methyl-1-hydro-indoly-5-methanesulfonamide
08/01/2007CN101007779A Method and device for making indole
08/01/2007CN101007277A Catalyst for synthesis of indole and its preparation method
07/2007
07/31/2007US7250526 Transfer hydrogenation process and catalyst
07/31/2007US7250516 Phenylalanine derivatives
07/31/2007US7250442 glucocorticoid, androgen, mineralcorticoid, estrogen and progesterone receptor modulators such as 3,3-Bis-(4-hydroxy-3,5-dimethyl-phenyl)-1-(4-methoxy-benzyl)-1,3-dihydro-indol-2-one, used for treating congestive heart failure
07/31/2007US7250441 Carbazole and cyclopentaindole derivatives to treat infection with Hepatitis C virus
07/31/2007US7250440 (Hydroxyphenyl)-1H-indole-3-carbaldehyde oxime derivatives as estrogenic agents
07/31/2007US7250439 For therapy of autoimmune disorder or an inflammatory condition
07/31/2007US7250415 1,1-Disubstitutedcycloalkyl-, glycinamidyl-, sulfonyl-amidino-, and tetrahydropyrimidinyl-containing diaminoalkyl, β-aminoacids, α-aminoacids and derivatives thereof as factor Xa inhibitors
07/31/2007CA2275306C Novel tetrahydrobenzindolone derivatives
07/26/2007WO2007084841A2 Sulfonyl substituted 1h-indoles as ligands for the 5-hydroxytryptamine receptors
07/26/2007WO2007084697A2 Process for preparing a crystalline form of tegaserod maleate
07/26/2007WO2007084435A2 Methods for treating hepatitis c
07/26/2007WO2007084413A2 Methods for treating hepatitis c
07/26/2007WO2007083732A1 Optical recording medium and azo metal chelate compound
07/26/2007WO2007064623A3 Methods for increasing the mean particle size of 2-hydrocarbyl-3,3-bis(hydroxyaryl)phthalimidines
07/26/2007WO2007058634B1 Stable formulation of amorphous perindopril salts, a process for their preparation, especially industrial preparation, and their use in the therapy of hypertension
07/26/2007WO2007056087A8 Prostaglandins and analogues as agents for lowering intraocular pressure